PMID: 11921273Mar 29, 2002Paper

Balanced chromosome abnormalities inv(16) and t(15;17) in therapy-related myelodysplastic syndromes and acute leukemia: report from an international workshop

Genes, Chromosomes & Cancer
Mette K AndersenJens Pedersen-Bjergaard

Abstract

The Workshop identified 48 unselected patients with therapy-related myelodysplastic syndrome or acute myeloid leukemia (t-MDS/t-AML) and inv(16), and 41 patients with t(15;17) after chemotherapy (CT) and/or radiotherapy (RT) for a malignant or nonmalignant disease. The primary diseases were: breast cancer, 33 patients; lymphomas, 24 patients; various other solid tumors, 30 patients; and nonmalignant diseases, 2 patients. The general type of previous therapy was RT only in 10 patients with an inv(16) and in 12 patients with a t(15;17), alkylating agents plus topoisomerase II inhibitors in 24 patients with an inv(16) and in 18 patients with a t(15;17), topoisomerase II inhibitors only in 5 patients with an inv(16) and in 2 patients with a t(15;17), alkylating agents only in 6 patients in each subgroup, and other types of chemotherapy in 3 patients in each subgroup. Most CT-treated patients (69%) also received RT. The latency period to development of t-MDS/t-AML was short: a median of 22 months in patients with inv(16) and 29 months in patients with t(15;17). Twenty-six patients (54%) with an inv(16) and 17 patients (41%) with a t(15;17) had additional cytogenetic abnormalities, which were unrelated to age and survival in both sub...Continue Reading

References

Apr 18, 2000·Mutation Research·F Mitelman
Jun 24, 2000·Leukemia·P M CarliM Maynadié
Dec 6, 2000·Annals of Oncology : Official Journal of the European Society for Medical Oncology·C LinassierP Colombat

❮ Previous
Next ❯

Citations

Mar 10, 2005·Journal of Clinical Laboratory Analysis·Roger S RileyJonathan M Ben-Ezra
Sep 1, 2011·Chinese Journal of Cancer Research = Chung-kuo Yen Cheng Yen Chiu·Yan MaHaiying Zen
Aug 21, 2007·Current Oncology Reports·Gautam Borthakur, And Elihu E Estey
Jun 19, 2013·Medical Oncology·Armin Rashidi, Stephen I Fisher
Apr 15, 2005·The New England Journal of Medicine·Anita R MistryDavid Grimwade
Aug 10, 2007·Journal of Toxicology and Environmental Health. Part B, Critical Reviews·David W PyattSean M Hays
Jul 1, 2009·Annals of Oncology : Official Journal of the European Society for Medical Oncology·V PullarkatS J Forman
Jun 26, 2004·Journal of Pediatric Hematology/oncology·Aya OgamiShinsaku Imashuku
Dec 17, 2005·The Journal of Clinical Investigation·Shinichiro NakadaShuki Mizutani
Nov 21, 2007·Hematology·Richard A Larson
Apr 2, 2009·Haematologica·Richard A Larson
Apr 4, 2014·Cell Biochemistry and Biophysics·Jin WangHualiang Xiao
Mar 2, 2010·Women's Health·Francesco Lo-CocoSafaa M Ramadan
Jun 7, 2006·Leukemia & Lymphoma·Jerry Mitchell, Yi-Kong Keung
Nov 26, 2010·Expert Review of Hematology·Karen W L Yee, Armand Keating
Oct 29, 2014·Expert Review of Hematology·Nicolas DuployezClaude Preudhomme
Mar 30, 2005·Expert Opinion on Drug Safety·Karen Seiter
Jun 2, 2006·Critical Reviews in Toxicology·Robert GoldenPeter G Shields
Oct 23, 2015·Journal of Clinical and Experimental Hematopathology : JCEH·Kazuyo YamamotoTakayuki Takahashi
Feb 18, 2012·American Journal of Clinical Pathology·Amy S DuffieldMilena Vuica-Ross
Aug 12, 2008·Seminars in Oncology·Lucy A Godley, Richard A Larson
Mar 6, 2007·Best Practice & Research. Clinical Haematology·Richard A Larson
May 10, 2005·Chemico-biological Interactions·David W PyattColleen A Cushing
Jun 7, 2005·Chemico-biological Interactions·Richard A Larson, Michelle M Le Beau
Jul 22, 2006·DNA Repair·Carolyn A FelixNeil Osheroff
Jun 2, 2006·Cancer Genetics and Cytogenetics·Attaphol PawarodeMaria R Baer
Jul 6, 2015·Current Treatment Options in Oncology·Simon B Zeichner, Martha L Arellano

❮ Previous
Next ❯

Related Concepts

Related Feeds

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.